-
1
-
-
4344669431
-
Protein structure, stability and solubility in water and other solvents
-
Pace CN, Trevino S, Prabhakaran E, Scholtz JM. Protein structure, stability and solubility in water and other solvents. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences. 2004; 359: 1225-35.
-
(2004)
Philosophical Transactions of the Royal Society of London Series B: Biological Sciences
, vol.359
, pp. 1225-1235
-
-
Pace, C.N.1
Trevino, S.2
Prabhakaran, E.3
Scholtz, J.M.4
-
3
-
-
80052963671
-
Myalgic encephalomyelitis: International consensus criteria
-
Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. Journal of internal medicine. 2011; 270: 327-38.
-
(2011)
Journal of Internal Medicine
, vol.270
, pp. 327-338
-
-
Carruthers, B.M.1
Van De Sande, M.I.2
De Meirleir, K.L.3
Klimas, N.G.4
Broderick, G.5
Mitchell, T.6
-
4
-
-
0027973857
-
The chronic fatigue syndrome: A comprehensive approach to its definition and study
-
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of internal medicine. 1994; 121: 953-9.
-
(1994)
Annals of Internal Medicine
, vol.121
, pp. 953-959
-
-
Fukuda, K.1
Straus, S.E.2
Hickie, I.3
Sharpe, M.C.4
Dobbins, J.G.5
Komaroff, A.6
-
5
-
-
0028118358
-
Immunologic abnormalities associated with chronic fatigue syndrome
-
Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA. Immunologic abnormalities associated with chronic fatigue syndrome. Clinical Infectious Diseases. 1994; 18: S136-S41.
-
(1994)
Clinical Infectious Diseases
, vol.18
, pp. 136-141
-
-
Barker, E.1
Fujimura, S.F.2
Fadem, M.B.3
Landay, A.L.4
Levy, J.A.5
-
6
-
-
79957440333
-
Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/ myalgic encephalomyelitis
-
Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, et al. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/ myalgic encephalomyelitis. J Transl Med. 2011; 9: 81.
-
(2011)
J Transl Med
, vol.9
, pp. 81
-
-
Brenu, E.W.1
Van Driel, M.L.2
Staines, D.R.3
Ashton, K.J.4
Ramos, S.B.5
Keane, J.6
-
7
-
-
61849132914
-
Immunological aspects of chronic fatigue syndrome
-
Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev. 2009 Feb;8(4):287-91.
-
(2009)
Autoimmun Rev
, vol.8
, Issue.4
, pp. 287-291
-
-
Ngonga, G.K.1
Ricevuti, G.2
-
8
-
-
0035004772
-
Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors
-
Patarca-Montero R, Antoni M, Fletcher MA, Klimas NG. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Applied Neuropsychology. 2001; 8: 51-64.
-
(2001)
Applied Neuropsychology
, vol.8
, pp. 51-64
-
-
Patarca-Montero, R.1
Antoni, M.2
Fletcher, M.A.3
Klimas, N.G.4
-
9
-
-
84930653890
-
Analysis of the relationship between immune dysfunction and symptom severity in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
-
Hardcastle S, Brenu E, Johnston S, Nguyen T, Huth T, Kaur M. Analysis of the relationship between immune dysfunction and symptom severity in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). J Clin Cell Immunol. 2014; 5: 2.
-
(2014)
J Clin Cell Immunol
, vol.5
, pp. 2
-
-
Hardcastle, S.1
Brenu, E.2
Johnston, S.3
Nguyen, T.4
Huth, T.5
Kaur, M.6
-
10
-
-
80054793227
-
Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study
-
Fluge Ø, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PloS one. 2011; 6: e26358.
-
(2011)
Plos One
, vol.6
-
-
Fluge, Ø.1
Bruland, O.2
Risa, K.3
Storstein, A.4
Kristoffersen, E.K.5
Sapkota, D.6
-
12
-
-
0037133285
-
Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year
-
Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002; 105: 804-9.
-
(2002)
Circulation
, vol.105
, pp. 804-809
-
-
Ziccardi, P.1
Nappo, F.2
Giugliano, G.3
Esposito, K.4
Marfella, R.5
Cioffi, M.6
-
15
-
-
71049161268
-
Plasma cytokines in women with chronic fatigue syndrome
-
Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009; 7: 96.
-
(2009)
J Transl Med
, vol.7
, pp. 96
-
-
Fletcher, M.A.1
Zeng, X.R.2
Barnes, Z.3
Levis, S.4
Klimas, N.G.5
-
16
-
-
0041885476
-
A systematic review and critical evaluation of the immunology of chronic fatigue syndrome
-
Lyall M, Peakman M, Wessely S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. Journal of psychosomatic research. 2003; 55: 79-90.
-
(2003)
Journal of Psychosomatic Research
, vol.55
, pp. 79-90
-
-
Lyall, M.1
Peakman, M.2
Wessely, S.3
-
18
-
-
0026199312
-
Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome
-
Chao CC, Janoff EN, Hu S, Thomas K, Gallagher M, Tsang M, et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine. 1991; 3: 292-8.
-
(1991)
Cytokine
, vol.3
, pp. 292-298
-
-
Chao, C.C.1
Janoff, E.N.2
Hu, S.3
Thomas, K.4
Gallagher, M.5
Tsang, M.6
-
20
-
-
0842330338
-
High levels of type 2 cytokine‐producing cells in chronic fatigue syndrome
-
Skowera A, Cleare A, Blair D, Bevis L, Wessely S, Peakman M. High levels of type 2 cytokine‐producing cells in chronic fatigue syndrome. Clinical & Experimental Immunology. 2004; 135: 294-302.
-
(2004)
Clinical & Experimental Immunology
, vol.135
, pp. 294-302
-
-
Skowera, A.1
Cleare, A.2
Blair, D.3
Bevis, L.4
Wessely, S.5
Peakman, M.6
-
21
-
-
78049413398
-
A formal analysis of cytokine networks in chronic fatigue syndrome
-
Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain, behavior, and immunity. 2010; 24: 1209-17.
-
(2010)
Brain, Behavior, and Immunity
, vol.24
, pp. 1209-1217
-
-
Broderick, G.1
Fuite, J.2
Kreitz, A.3
Vernon, S.D.4
Klimas, N.5
Fletcher, M.A.6
-
22
-
-
0034663813
-
Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18
-
Lauwerys BR, Garot N, Renauld J-C, Houssiau FA. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. The Journal of Immunology. 2000; 165: 1847-53.
-
(2000)
The Journal of Immunology
, vol.165
, pp. 1847-1853
-
-
Lauwerys, B.R.1
Garot, N.2
Renauld, J.-C.3
Houssiau, F.A.4
-
23
-
-
84857359512
-
Evidence for inflammation and activation of cell-mediated immunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin
-
Maes M, Twisk FN, Kubera M, Ringel K. Evidence for inflammation and activation of cell-mediated immunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. Journal of affective disorders. 2012; 136: 933-9.
-
(2012)
Journal of Affective Disorders
, vol.136
, pp. 933-939
-
-
Maes, M.1
Twisk, F.N.2
Kubera, M.3
Ringel, K.4
-
24
-
-
39749182247
-
Antibody diversification by somatic mutation: From Burnet onwards
-
Neuberger MS. Antibody diversification by somatic mutation: from Burnet onwards. Immunology and cell biology. 2008; 86: 124-32.
-
(2008)
Immunology and Cell Biology
, vol.86
, pp. 124-132
-
-
Neuberger, M.S.1
-
26
-
-
56549115782
-
Modulation of the cellular immune system by intravenous immunoglobulin
-
Tha-In T, Bayry J, Metselaar HJ, Kaveri SV, Kwekkeboom J. Modulation of the cellular immune system by intravenous immunoglobulin. Trends in immunology. 2008; 29: 608-15.
-
(2008)
Trends in Immunology
, vol.29
, pp. 608-615
-
-
Tha-In, T.1
Bayry, J.2
Metselaar, H.J.3
Kaveri, S.V.4
Kwekkeboom, J.5
-
27
-
-
0030010390
-
Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions
-
Kwak J, Kwak F, Ainbinder S, Ruiz A, Beer A. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. American Journal of Reproductive Immunology. 1996; 35: 363-9.
-
(1996)
American Journal of Reproductive Immunology
, vol.35
, pp. 363-369
-
-
Kwak, J.1
Kwak, F.2
Ainbinder, S.3
Ruiz, A.4
Beer, A.5
-
28
-
-
85026347818
-
Distinct plasma immune signatures in ME/CFS are present early in the course of illness
-
Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Science Advances. 2015; 1: e1400121.
-
(2015)
Science Advances
, vol.1
-
-
Hornig, M.1
Montoya, J.G.2
Klimas, N.G.3
Levine, S.4
Felsenstein, D.5
Bateman, L.6
-
29
-
-
84875025715
-
Best-Practice Recommendations for Defining, Identifying, and Handling Outliers
-
Aguinis H, Gottfredson RK, Joo H. Best-Practice Recommendations for Defining, Identifying, and Handling Outliers. Organizational Research Methods. 2013; 16: 270-301.
-
(2013)
Organizational Research Methods
, vol.16
, pp. 270-301
-
-
Aguinis, H.1
Gottfredson, R.K.2
Joo, H.3
-
30
-
-
0036096375
-
Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease
-
Evereklioglu C, Er H, Türköz Y, Çekmen M. Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediators of inflammation. 2002; 11: 87-93.
-
(2002)
Mediators of Inflammation
, vol.11
, pp. 87-93
-
-
Evereklioglu, C.1
Er, H.2
Türköz, Y.3
Çekmen, M.4
-
31
-
-
78650970845
-
Innate or adaptive immunity? The example of natural killer cells
-
Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011; 331: 44-9.
-
(2011)
Science
, vol.331
, pp. 44-49
-
-
Vivier, E.1
Raulet, D.H.2
Moretta, A.3
Caligiuri, M.A.4
Zitvogel, L.5
Lanier, L.L.6
-
32
-
-
84860867111
-
Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis
-
Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2012; 10: 88.
-
(2012)
J Transl Med
, vol.10
, pp. 88
-
-
Brenu, E.W.1
Van Driel, M.L.2
Staines, D.R.3
Ashton, K.J.4
Hardcastle, S.L.5
Keane, J.6
-
33
-
-
0036486763
-
Role of chemokines in the biology of natural killer cells
-
Robertson MJ. Role of chemokines in the biology of natural killer cells. Journal of leukocyte biology. 2002; 71: 173-83.
-
(2002)
Journal of Leukocyte Biology
, vol.71
, pp. 173-183
-
-
Robertson, M.J.1
-
34
-
-
0031883887
-
CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-γ production and increased sensitivity to dexamethasone
-
Visser J, Blauw B, Hinloopen B, Brommer E, de Kloet ER, Kluft C, et al. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-γ production and increased sensitivity to dexamethasone. Journal of Infectious Diseases. 1998; 177: 451-4.
-
(1998)
Journal of Infectious Diseases
, vol.177
, pp. 451-454
-
-
Visser, J.1
Blauw, B.2
Hinloopen, B.3
Brommer, E.4
De Kloet, E.R.5
Kluft, C.6
-
35
-
-
0026534761
-
Serum levels of lymphokines and soluble cellular receptors in primary Epstein- Barr virus infection and in patients with chronic fatigue syndrome
-
Linde A, Andersson B, Svenson SB, Ahrne H, Carlsson M, Forsberg P, et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein- Barr virus infection and in patients with chronic fatigue syndrome. Journal of Infectious Diseases. 1992; 165: 994-1000.
-
(1992)
Journal of Infectious Diseases
, vol.165
, pp. 994-1000
-
-
Linde, A.1
Ersson, B.2
Svenson, S.B.3
Ahrne, H.4
Carlsson, M.5
Forsberg, P.6
-
36
-
-
0031031874
-
Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation
-
Peakman M, Deale A, Field R, Mahalingam M, Wessely S. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clinical immunology and immunopathology. 1997; 82: 83-91.
-
(1997)
Clinical Immunology and Immunopathology
, vol.82
, pp. 83-91
-
-
Peakman, M.1
Deale, A.2
Field, R.3
Mahalingam, M.4
Wessely, S.5
-
37
-
-
84897935737
-
Immune abnormalities in patients meeting new diagnostic criteria for chronic fatigue syndrome/Myalgic Encephalomyelitis
-
Brenu E, Johnston S, Hardcastle S, Huth T, Fuller K, Ramos S, et al. Immune abnormalities in patients meeting new diagnostic criteria for chronic fatigue syndrome/Myalgic Encephalomyelitis. J Mol Biomark Diagn. 2013; 4: 4172.
-
(2013)
J Mol Biomark Diagn
, vol.4
, pp. 4172
-
-
Brenu, E.1
Johnston, S.2
Hardcastle, S.3
Huth, T.4
Fuller, K.5
Ramos, S.6
-
38
-
-
0031012504
-
Human Th1 cells preferentially induce interleukin (IL)-1beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes
-
Chizzolini C, Chicheportiche R, Burger D, Dayer JM. Human Th1 cells preferentially induce interleukin (IL)-1beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes. Eur J Immunol. 1997; 27: 171-7.
-
(1997)
Eur J Immunol
, vol.27
, pp. 171-177
-
-
Chizzolini, C.1
Chicheportiche, R.2
Burger, D.3
Dayer, J.M.4
-
39
-
-
0035375779
-
IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: Interaction with their plasma levels
-
Buchs N, Di Giovine F, Silvestri T, Vannier E, Duff G, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes and immunity. 2001; 2: 222-8.
-
(2001)
Genes and Immunity
, vol.2
, pp. 222-228
-
-
Buchs, N.1
Di Giovine, F.2
Silvestri, T.3
Vannier, E.4
Duff, G.5
Miossec, P.6
-
40
-
-
0032899896
-
IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease
-
Nemetz A, Nosti-Escanilla MP, Molnár T, Köpe A, Kovács Á, Fehér J, et al. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics. 1999; 49: 527-31.
-
(1999)
Immunogenetics
, vol.49
, pp. 527-531
-
-
Nemetz, A.1
Nosti-Escanilla, M.P.2
Molnár, T.3
Köpe, A.4
Kovács, Á.5
Fehér, J.6
-
41
-
-
33645000725
-
In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation
-
Maes M, Mihaylova I, Leunis J-C. In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation. Neuroendocrinology Letters. 2005; 26: 745-51.
-
(2005)
Neuroendocrinology Letters
, vol.26
, pp. 745-751
-
-
Maes, M.1
Mihaylova, I.2
Leunis, J.-C.3
-
42
-
-
8744242039
-
Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans
-
Vollmer-Conna U, Fazou C, Cameron B, Li H, Brennan C, Luck L, et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychological medicine. 2004; 34: 1289-97.
-
(2004)
Psychological Medicine
, vol.34
, pp. 1289-1297
-
-
Vollmer-Conna, U.1
Fazou, C.2
Cameron, B.3
Li, H.4
Brennan, C.5
Luck, L.6
-
43
-
-
0031779807
-
Tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis
-
Evans CA, Jellis J, Hughes SP, Remick DG, Friedland JS. Tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis. Journal of Infectious Diseases. 1998; 177: 1582-7.
-
(1998)
Journal of Infectious Diseases
, vol.177
, pp. 1582-1587
-
-
Evans, C.A.1
Jellis, J.2
Hughes, S.P.3
Remick, D.G.4
Friedland, J.S.5
-
45
-
-
0036694589
-
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
-
Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine & growth factor reviews. 2002; 13: 357-68.
-
(2002)
Cytokine & Growth Factor Reviews
, vol.13
, pp. 357-368
-
-
Ishihara, K.1
Hirano, T.2
-
46
-
-
0002307117
-
Dysregulated expression of soluble immune mediator receptors in a subset of patients with chronic fatigue syndrome: Cross-sectional categorization of patients by immune status
-
Patarca R, Klimas NG, Garcia MN, Walters MJ, Dombroski D, Pons H, et al. Dysregulated expression of soluble immune mediator receptors in a subset of patients with chronic fatigue syndrome: cross-sectional categorization of patients by immune status. Journal of Chronic Fatigue Syndrome. 1995; 1: 81-96.
-
(1995)
Journal of Chronic Fatigue Syndrome
, vol.1
, pp. 81-96
-
-
Patarca, R.1
Klimas, N.G.2
Garcia, M.N.3
Walters, M.J.4
Dombroski, D.5
Pons, H.6
-
49
-
-
84875062805
-
Screening NK-, B-and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome
-
Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, et al. Screening NK-, B-and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. Journal of translational medicine. 2013; 11: 68.
-
(2013)
Journal of Translational Medicine
, vol.11
, pp. 68
-
-
Curriu, M.1
Carrillo, J.2
Massanella, M.3
Rigau, J.4
Alegre, J.5
Puig, J.6
-
50
-
-
79960839437
-
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
-
Gunther V, Putnak R, Eckels K, Mammen M, Scherer J, Lyons A, et al. A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine. 2011; 29: 3895-904.
-
(2011)
Vaccine
, vol.29
, pp. 3895-3904
-
-
Gunther, V.1
Putnak, R.2
Eckels, K.3
Mammen, M.4
Scherer, J.5
Lyons, A.6
-
52
-
-
77649165460
-
Immune and hemorheological changes in chronic fatigue syndrome
-
Brenu EW, Staines DR, Baskurt OK, Ashton KJ, Ramos SB, Christy RM, et al. Immune and hemorheological changes in chronic fatigue syndrome. Journal of translational medicine. 2010; 8: 1.
-
(2010)
Journal of Translational Medicine
, vol.8
, pp. 1
-
-
Brenu, E.W.1
Staines, D.R.2
Baskurt, O.K.3
Ashton, K.J.4
Ramos, S.B.5
Christy, R.M.6
-
53
-
-
30744447910
-
CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection
-
Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O’Sullivan MP, et al. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nature medicine. 2005; 11: 1180-7.
-
(2005)
Nature Medicine
, vol.11
, pp. 1180-1187
-
-
Tyner, J.W.1
Uchida, O.2
Kajiwara, N.3
Kim, E.Y.4
Patel, A.C.5
O’Sullivan, M.P.6
-
54
-
-
33748751102
-
CCL5-CCR5-mediated Apoptosis in T Cells REQUIREMENT FOR GLYCOSAMINOGLYCAN BINDING AND CCL5 AGGREGATION
-
Murooka TT, Wong MM, Rahbar R, Majchrzak-Kita B, Proudfoot AE, Fish EN. CCL5-CCR5-mediated Apoptosis in T Cells REQUIREMENT FOR GLYCOSAMINOGLYCAN BINDING AND CCL5 AGGREGATION. Journal of Biological Chemistry. 2006; 281: 25184-94.
-
(2006)
Journal of Biological Chemistry
, vol.281
, pp. 25184-25194
-
-
Murooka, T.T.1
Wong, M.M.2
Rahbar, R.3
Majchrzak-Kita, B.4
Proudfoot, A.E.5
Fish, E.N.6
-
55
-
-
85019299733
-
Natural killer cells in patients with severe chronic fatigue syndrome
-
Brenu, Hardcastle, Atkinson G, van Driel M, Kreijkamp-Kaspers S, Ashton K, et al. Natural killer cells in patients with severe chronic fatigue syndrome. Autoimmunity Highlights. 2013: 1-12.
-
(2013)
Autoimmunity Highlights
, pp. 1-12
-
-
Brenu, H.1
Atkinson, G.2
Van Driel, M.3
Kreijkamp-Kaspers, S.4
Ashton, K.5
|